key: cord-0721085-w3t4v12y authors: Li, Xiujun; Wang, Yanchao; Wang, Hongquan; Wang, Yumin title: SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease date: 2021-05-27 journal: QJM DOI: 10.1093/qjmed/hcab157 sha: e539a392024fba44800fbf141b6ffc1e33f5de80 doc_id: 721085 cord_uid: w3t4v12y Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been linked to the Guillain-Barré syndrome (GBS). The objective of the present study is to identify specific clinical features of cases of GBS reported in the literature associated with SARS-CoV-2 infection. We searched Pubmed, and included single case reports and case series with full text in English, reporting original data of patients with GBS and a confirmed recent SARS-CoV-2 infection. Clinical data were extracted.We identified 28 articles (22 single case reports and 6 case series), reporting on a total of 44 GBS patients with confirmed SARS-CoV-2 infection. SARS-CoV-2 infection was confirmed through serum RT-PCR in 72.7% of cases. A total of 40 patients (91%) had symptoms compatible with SARS-CoV-2 infection before the onset of the GBS. The median period between the onset of symptoms of SARS-CoV-2 infection and symptoms of the GBS was 11.2 days (range, 2-23). The most common clinical features were: leg weakness (61.4%), leg parethesia (50%), arm weakness (50.4%), arm paresthesia (50.4%), hyporeflexia/areflexia (48%), and ataxia (22.7%). 38.6% (n = 17) were found to have facial paralysis. Among 37 patients in whom nerve-conduction studies and electromyography were performed, of which 14 patients (31.8%) were consistent with the acute inflammatory demyelinating polyneuropathy (AIDP) subtype of the GBS. The present retrospective analysis support the role of the SARS-CoV-2 infection in the development of the GBS, may trigger GBS as para-infectious disease, and lead to SARS-CoV-2-associated GBS. Guillain-Barré syndrome (GBS) is an uncommon acute immune-mediated polyradiculoneuropathy of the peripheral nervous system typically characterized by progressive, symmetric limb weakness with decreased or absent deep-tendon reflexes 1 , often preceded by respiratory or gastrointestinal infections from a virus or bacteria. About 70% of patients with GBS report having had symptoms of an infectious illness in the days or weeks prior to onset of neurologic disease. Certain lines of evidence suggest that GBS is presumed to be triggered by preceding infectious agents including Campylobacter jejuni, Mycoplasma pneumoniae, cytomegalovirus, and Epstein-Barr virus and less frequently with vaccines [2] [3] [4] . The global annual GBS incidence is estimated at 1.1 to 1.8 cases per 100 000 population, which may vary depending on the regional prevalence of infectious triggers ， and increase with age and varying by sex and geographic region 5 . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an enveloped, single-stranded RNA virus, causing human coronavirus disease 2019 (COVID- 19) , has now spread into a worldwide pandemic. SARS-CoV-2 infection manifests as a pulmonary syndrome associated with fever, cough, hemoptysis, and dyspnea, among others 6, 7 . There is growing evidence of neurological complications and disease in patients with COVID-19 [8] [9] [10] [11] . Due to its worldwide distribution and multifactorial pathogenic mechanisms, COVID-19 have imposed a global threat to the entire nervous system 12 . SARS-CoV-2 infection is associated with the GBS and its variants in the peripheral nervous system. Since the SARS-CoV-2 epidemics, numerous studies have been published on SARS-CoV-2-related GBS [13] [14] [15] [16] [17] included. The final list of included articles was generated based on relevance to the GBS covered in this review, which includes total of 28 articles. We identified 28 articles( 22 single case reports and 6 case series) ( profile of GBS. Given the temporal association, the present study support the notion that GBS might have been triggered by humoral immune response against SARS-CoV2 in these patients 23 . The present analysis of cases with GBS substantiate the previous hypothesis that SARS-CoV-2 may trigger GBS as para-infectious or post-infectious disease as did by Zika virus 24 . The limitation of this study is that the lack of an epidemiological study to 27 .This data suggested that increased GBS incidence during SARS-CoV-2 epidemics，which has provided a unique opportunity to further delineate the clinical features and pathophysiology of GBS. But at the same time one study have determined if clusters of the GBS have been spatially and temporally related to the current SARS-CoV-2 epidemic, the epidemiological and cohort study finds no association between COVID-19 and GBS 28 . In Conflict of interest. None declared. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 https://mc.manuscriptcentral.com/qjm Manuscripts submitted to QJM: An International Journal of Medicine 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 AIDP : acute inflammatory demyelinating polyneuropathy; AMAN:acute motor axonal neuropathy;AMSAN: acute motor and sensory axonal neuropathy; MFS: Miller-Fisher syndrome NPS:nasopharyngeal swab; SMA: Sensory-Motor Axonal; AMA: Acute Motor Axonal; PE: plasma exchange Guillain-Barré syndrome Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study Campylobacter jejuni infection and Guillain-Barré syndrome Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 Neurological manifestations associated with COVID-19: a review and a call for action The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms COVID-19: a global threat to the nervous system A Case Series of Guillain-Barré Syndrome following Covid-19 Infection COVID-19 may induce Guillain-Barré syndrome Covid-19 and Guillain-Barré syndrome: More than a coincidence Guillain-Barré Syndrome Associated with SARS-CoV-2 Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review Guillain-Barré syndrome, transverse myelitis and infectious diseases Manuscripts submitted to QJM: An International Journal of Medicine Preceding infections, immune factors, and outcome in Guillain-Barré syndrome Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2 Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome Guillain Barre syndrome associated with COVID-19 infection: A case report Syndrome associated with SARS-CoV-2 infection Guillain-Barré syndrome related to COVID-19 infection A Case Series of Guillain-Barré Syndrome following Covid-19 Infection Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital Guillain-Barré syndrome after SARS-CoV-2 infection SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature Guillain-Barré syndrome following COVID-19: new infection, old complication Miller-Fisher syndrome after SARS-CoV-2 infection Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2 COVID-19-Associated Miller Fisher Syndrome: MRI Findings Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome Manuscripts submitted to QJM: An International Journal of Medicine Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster Guillain-Barré syndrome as a complication of SARS-CoV-2 infection Guillain-Barré syndrome related to SARS-CoV-2 infection Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report Fatal Guillain-Barre syndrome after infection with SARS-CoV-2 Guillain-Barré syndrome associated with SARS-CoV-2 infection Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection Manuscripts submitted to QJM